NM_001267550.2:c.57212T>C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_001267550.2(TTN):āc.57212T>Cā(p.Ile19071Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000395 in 1,613,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | c.57212T>C | p.Ile19071Thr | missense_variant | Exon 293 of 363 | ENST00000589042.5 | NP_001254479.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | c.57212T>C | p.Ile19071Thr | missense_variant | Exon 293 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 | 
Frequencies
GnomAD3 genomes  0.000342  AC: 52AN: 152118Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.000318  AC: 79AN: 248686 AF XY:  0.000289   show subpopulations 
GnomAD4 exome  AF:  0.000400  AC: 585AN: 1461194Hom.:  0  Cov.: 33 AF XY:  0.000378  AC XY: 275AN XY: 726868 show subpopulations 
Age Distribution
GnomAD4 genome  0.000342  AC: 52AN: 152236Hom.:  0  Cov.: 32 AF XY:  0.000349  AC XY: 26AN XY: 74426 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:5Benign:5 
- -
- -
- -
- -
TTN: PM2 -
- -
- -
- -
- -
The TTN c.57212T>C; p.Ile19071Thr variant (rs200001206; ClinVar Variation ID:47118) is rare in the general population (<0.2% allele frequency in the Genome Aggregation Database) and has not been reported in the medical literature in association with dilated cardiomyopathy (DCM) or other TTN-related disease. The clinical relevance of rare missense variants in this gene, which are identified on average once per individual sequenced in affected populations (Herman 2012), is not well understood. Yet, evidence suggests that the vast majority of such missense variants do not contribute to the clinical outcome of DCM (Begay 2015). Thus, the clinical significance of the p.Ile19071Thr variant cannot be determined with certainty. References: Begay RL et al. Role of Titin Missense Variants in Dilated Cardiomyopathy. J Am Heart Assoc. 2015 Nov 13;4(11). PMID: 26567375. Herman DS et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012 Feb 16;366(7):619-28. PMID: 22335739. Linke WA and Hamdani N. Gigantic business: titin properties and function through thick and thin. Circ Res 2014; 114(6): 1052-1068. PMID: 24625729. -
not specified    Uncertain:1Benign:2 
- -
Variant summary: TTN c.49508T>C (p.Ile16503Thr), also reported as NM_001267550:c.57212T>C (p.Ile19071Thr), results in a non-conservative amino acid change located in the A-band region of the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00039 in 1613430 control chromosomes, predominantly at a frequency of 0.00047 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 1.2 fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039). c.49508T>C has been reported in the literature in individuals affected with sudden cardiac death (example, Hertz_2016). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 26383259). ClinVar contains an entry for this variant (Variation ID: 47118). Based on the evidence outlined above, the variant was classified as likely benign. -
The Ile16503Thr variant in TTN has been identified in 1/3071 African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS). This frequency is insufficient to rule out pathogeni city as this may have been a presymptomatic individual. Isoleucine (Ile) at posi tion 16503 is not well conserved in evolution, suggesting that a change may be t olerated though this is not predictive enough to rule out pathogenicity. Other computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein . Additional information is needed to fully assess the clinical significance of the Ile16503Thr variant. -
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G    Uncertain:1 
- -
Cardiovascular phenotype    Uncertain:1 
The p.I10006T variant (also known as c.30017T>C), located in coding exon 120 of the TTN gene, results from a T to C substitution at nucleotide position 30017. The isoleucine at codon 10006 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Cardiomyopathy    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at